Patrick Donnelly
Stock Analyst at Citigroup
(3.88)
# 690
Out of 4,711 analysts
307
Total ratings
54.82%
Success rate
7.75%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FTRE Fortrea Holdings | Downgrades: Neutral | $30 → $23 | $19.26 | +19.42% | 4 | Dec 11, 2024 | |
ILMN Illumina | Downgrades: Neutral | $190 → $165 | $136.02 | +21.31% | 14 | Dec 11, 2024 | |
MTD Mettler-Toledo International | Upgrades: Neutral | $1,200 → $1,300 | $1,230.74 | +5.63% | 11 | Dec 11, 2024 | |
QDEL QuidelOrtho | Upgrades: Buy | $44 → $50 | $44.84 | +11.51% | 4 | Dec 11, 2024 | |
SHC Sotera Health Company | Maintains: Buy | $18 → $20 | $13.24 | +51.06% | 3 | Nov 6, 2024 | |
BRKR Bruker | Maintains: Buy | $80 → $75 | $57.00 | +31.58% | 14 | Nov 6, 2024 | |
EXAS Exact Sciences | Maintains: Buy | $80 → $75 | $59.40 | +26.26% | 13 | Nov 6, 2024 | |
BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $450 | $327.47 | +37.42% | 14 | Oct 31, 2024 | |
BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $450 | $325.85 | +38.10% | 14 | Oct 31, 2024 | |
TXG 10x Genomics | Maintains: Buy | $35 → $23 | $14.04 | +63.82% | 10 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $185 | $153.10 | +20.84% | 10 | Oct 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $95 → $85 | $71.65 | +18.63% | 13 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $215 → $175 | $185.77 | -5.80% | 19 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $134.51 | +22.67% | 26 | Aug 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $31.67 | +42.09% | 9 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $20.56 | +36.19% | 4 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $112.56 | +28.82% | 1 | Jul 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $21.21 | +8.44% | 7 | Jul 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $85 | $73.17 | +16.17% | 10 | May 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $290 | $228.55 | +26.89% | 10 | Apr 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Neutral | $620 | $524.05 | +18.31% | 17 | Mar 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $60 | $44.67 | +34.32% | 13 | Feb 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $368.16 | -18.51% | 24 | Dec 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.64 | +147.25% | 6 | Dec 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $225 | $197.27 | +14.06% | 9 | Dec 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $315 | $207.51 | +51.80% | 7 | Dec 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $8.78 | -68.68% | 4 | Aug 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $228.61 | +13.73% | 11 | Feb 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $5.75 | +4.35% | 4 | Nov 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $13.36 | +139.52% | 2 | Nov 30, 2018 |
Fortrea Holdings
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $19.26
Upside: +19.42%
Illumina
Dec 11, 2024
Downgrades: Neutral
Price Target: $190 → $165
Current: $136.02
Upside: +21.31%
Mettler-Toledo International
Dec 11, 2024
Upgrades: Neutral
Price Target: $1,200 → $1,300
Current: $1,230.74
Upside: +5.63%
QuidelOrtho
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $44.84
Upside: +11.51%
Sotera Health Company
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $13.24
Upside: +51.06%
Bruker
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $57.00
Upside: +31.58%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $59.40
Upside: +26.26%
Bio-Rad Laboratories
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $327.47
Upside: +37.42%
Bio-Rad Laboratories
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $325.85
Upside: +38.10%
10x Genomics
Oct 30, 2024
Maintains: Buy
Price Target: $35 → $23
Current: $14.04
Upside: +63.82%
Oct 23, 2024
Maintains: Buy
Price Target: $165 → $185
Current: $153.10
Upside: +20.84%
Oct 1, 2024
Downgrades: Neutral
Price Target: $95 → $85
Current: $71.65
Upside: +18.63%
Oct 1, 2024
Downgrades: Sell
Price Target: $215 → $175
Current: $185.77
Upside: -5.80%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $134.51
Upside: +22.67%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $31.67
Upside: +42.09%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $20.56
Upside: +36.19%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $112.56
Upside: +28.82%
Jul 10, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $21.21
Upside: +8.44%
May 22, 2024
Downgrades: Neutral
Price Target: $85
Current: $73.17
Upside: +16.17%
Apr 24, 2024
Maintains: Buy
Price Target: $280 → $290
Current: $228.55
Upside: +26.89%
Mar 18, 2024
Reinstates: Neutral
Price Target: $620
Current: $524.05
Upside: +18.31%
Feb 8, 2024
Maintains: Buy
Price Target: $62 → $60
Current: $44.67
Upside: +34.32%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $368.16
Upside: -18.51%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.64
Upside: +147.25%
Dec 11, 2023
Maintains: Neutral
Price Target: $190 → $225
Current: $197.27
Upside: +14.06%
Dec 11, 2023
Maintains: Buy
Price Target: $300 → $315
Current: $207.51
Upside: +51.80%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $8.78
Upside: -68.68%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $228.61
Upside: +13.73%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $5.75
Upside: +4.35%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $13.36
Upside: +139.52%